Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos)

SUMMARY: We determined the prospective 10-year association among incident fragility fractures and four glucocorticoid (GC) treatment groups (Never GC, Prior GC, Baseline GC, and Ever GC). Results showed that GC treatment is associated with increased 10-year incident fracture risk in ambulatory men a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arch Osteoporos
Hlavní autoři: Ioannidis, George, Pallan, Shelley, Papaioannou, Alexandra, Mulgund, Manisha, Rios, Lorena, Ma, Jinhui, Thabane, Lehana, Davison, Kenneth S., Josse, Robert G., Kovacs, Christopher S., Kreiger, Nancy, Olszynski, Wojciech P., Prior, Jerilynn C., Towheed, Tanveer, Adachi, Jonathan D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5112017/
https://ncbi.nlm.nih.gov/pubmed/24577853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11657-013-0169-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky